Compare AU
Compare TECH vs. DRUG
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, Exchange-Traded Funds (ETFs) are a popular choice. Two well-known options in the Australian Securities Exchange (ASX) are the Global X Morningstar Global Technology ETF (TECH) and the BetaShares Global Healthcare Currency Hedged ETF (DRUG). In this comparison, we'll delve into these ETFs across various dimensions to help you make an informed investment decision.
Community Stats
TECH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 180 | 61 |
Median incremental investment | $711.41 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,119.40 | $1,976.53 |
Average age group | > 35 | 26 - 35 |
Key Summary
TECH | DRUG | |
|---|---|---|
Strategy | The Global X Morningstar Global Technology ETF (TECH: ASX) seeks to track the performance of the Morningstar Developed Markets Technology Moat Focus Index before considering any fees, expenses, or taxes. | DRUG.AX was created on 2016-08-04 by BetaShares. The fund's investment portfolio concentrates primarily on health care equity. DRUG.AX aims to track the performance of an index (before fees and expenses) that comprises the largest global healthcare companies (ex-Australia), hedged into Australian dollars. |
Top 3 holdings | Sony Group Corp (4.81 %) Adyen NV (4.73 %) Uber Technologies Inc (4.73 %) | CHF - SWISS FRANC (0 %) AUD - AUSTRALIA DOLLAR (0 %) DKK - DANISH KRONE (0 %) |
Top 3 industries | Information Technology (47.33 %) Industrials (30.36 %) Consumer Discretionary (11.37 %) | Other (75.92 %) Communication Services (33.53 %) Health Care (23.94 %) |
Top 3 countries | United States (76.16 %) Netherlands (7.48 %) Japan (5.55 %) | United States (71.71 %) Switzerland (8.14 %) Denmark (6.30 %) |
Management fee | 0.45 % | 0.57 % |
Key Summary
TECH | DRUG | |
|---|---|---|
Issuer | Global X | BetaShares |
Tracking index | Morningstar Developed Markets Technology Moat Focus Index - USD | Nasdaq Global ex-Australia Healthcare Hedged AUD Index - AUD |
Asset class | ETF | ETF |
Management fee | 0.45 % | 0.57 % |
Price | $105.97 | $8.27 |
Size | $363.782 million | $195.730 million |
10Y return | N/A | N/A |
Annual distribution yield (5Y) | 7.45 % | 1.89 % |
Market | ASX | ASX |
First listed date | 11/04/2017 | 08/08/2016 |
Purchase fee | $6.50 | $6.50 |
Community Stats
TECH | DRUG | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 180 | 61 |
Median incremental investment | $711.41 | $920.50 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,119.40 | $1,976.53 |
Average age group | > 35 | 26 - 35 |
Pros and Cons
TECH | DRUG | |
|---|---|---|
Pros |
| |
Cons |
|
TECH | DRUG |
|---|---|
Higher exposure to US market | Lower exposure to US market |
Lower management fee | Higher management fee |
Higher price growth | Lower price growth |
Higher distribution yield | Lower distribution yield |